Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)

2025-10-01 07:04:21 ET

Leading provider of prepaid cards and patient affordability solutions, Paysign, Inc. ( PAYS ), recently posted its earnings results, with revenues jumping 33.12% year-over-year (YoY) in Q2 2025. The company was ecstatic about its business prospects for H2 2025 and 2026, indicating the consistency of its results with its guidance. I will discuss why I am rating this stock as a hold in line with the expected high demand from the pharmaceutical sector for the company’s co-payment cards, fueled partly by US tariffs, client increase, and expanded patient affordability programs. However, the company’s stock is trading at a fair valuation, as will be seen herein....

Read the full article on Seeking Alpha

For further details see: